CIK 0000200406
- Large accelerated filer
JOHNSON & JOHNSON
Sign in to watch- Ticker
- JNJ
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Jan 3
- Incorporated
- NJ
- Entity type
- Operating
- EIN
- 221024240
- Phone
- +1 732-524-2455
- Business address
- ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK, NJ, 08933
- Former names
- JOHNSON & JOHNSON ET AL
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $12,947,986
- in 2 filings
Net −$12,947,986. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-12-06 | WEINBERGER MARK A Director | Grant or award · Deferred Share Units | +241.02 | $178.70 | $43K | 6,276.05 |
| 2022-12-06 | Washington A. Eugene Director | Grant or award · Deferred Share Units | +350.74 | $178.70 | $63K | 28,162.94 |
| 2022-12-06 | HEWSON MARILLYN A Director | Grant or award · Deferred Share Units | +240.47 | $178.70 | $43K | 6,152.49 |
| 2022-11-30 | McEvoy Ashley EVP, WW Chair, MedTech | Exercise or conversion | +73,323 | $72.54 | $5.3M | 115,135.95 |
| 2022-11-30 | McEvoy Ashley EVP, WW Chair, MedTech | Sale | −1,400 | $176.09 | $247K | 113,735.95 |
| 2022-11-30 | McEvoy Ashley EVP, WW Chair, MedTech | Sale | −71,923 | $175.46 | $12.6M | 41,812.95 |
| 2022-11-30 | McEvoy Ashley EVP, WW Chair, MedTech | Exercise or conversion · Employee Stock Options (Right to Buy) | −73,323 | 0 | ||
| 2022-11-22 | Taubert Jennifer L EVP, WW Chair, Pharmaceuticals | Exercise or conversion | +76,923 | $72.54 | $5.6M | 203,379 |
| 2022-11-22 | Taubert Jennifer L EVP, WW Chair, Pharmaceuticals | Sale | −76,923 | $176.78 | $13.6M | 126,456 |
| 2022-11-22 | Taubert Jennifer L EVP, WW Chair, Pharmaceuticals | Exercise or conversion · Employee Stock Options (Right to Buy) | −76,923 | 0 | ||
| 2022-11-18 | Decker Robert J Controller, CAO | Exercise or conversion | +16,928 | $90.44 | $1.5M | 32,401 |
| 2022-11-18 | Decker Robert J Controller, CAO | Sale | −16,928 | $175.00 | $3.0M | 15,473 |
| 2022-11-18 | Decker Robert J Controller, CAO | Exercise or conversion · Employee Stock Options (Right to Buy) | −16,928 | 0 | ||
| 2022-11-09 | Wengel Kathryn E EVP, Chief GSC Officer | Exercise or conversion | +16,410 | $72.54 | $1.2M | 87,720.87 |
| 2022-11-09 | Wengel Kathryn E EVP, Chief GSC Officer | Sale | −16,410 | $173.42 | $2.8M | 71,310.87 |
| 2022-11-09 | Wengel Kathryn E EVP, Chief GSC Officer | Exercise or conversion · Employee Stock Options (Right to Buy) | −16,410 | 0 | ||
| 2022-11-07 | Mongon Thibaut Exec VP, WW Chair, Consumer | Exercise or conversion | +10,033 | $115.67 | $1.2M | 50,166.27 |
| 2022-11-07 | Mongon Thibaut Exec VP, WW Chair, Consumer | Exercise or conversion | +7,010 | $101.87 | $714K | 57,176.27 |
| 2022-11-07 | Mongon Thibaut Exec VP, WW Chair, Consumer | Exercise or conversion · Employee Stock Options (Right to Buy) | −7,010 | $101.87 | $714K | 0 |
| 2022-11-07 | Mongon Thibaut Exec VP, WW Chair, Consumer | Exercise or conversion · Employee Stock Options (Right to Buy) | −10,033 | $115.67 | $1.2M | 0 |
Page 40 of 60 · 1,189 trades